Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition
9 May 2026 – 14 May 2026 · Cape Town, South Africa
367-02-006 ISMRM Abstract

Multiparametric 1H/23Na MRI for analysing the ionic microenvironment within preclinical breast tumour models.

Primary: Preclinical Animal & in vitro MR - Small Animals
Secondary: Body - Breast
367-02-006 · Cancer Detection and Therapies · Monday, 11 May, 9:15 AM–10:10 AM · Digital Posters Row H
Keywords: Breast cancer CEST MRI in vivo Cancer metabolism 23Na-MRI Hypoxia
Accepted
Alina Lavinia Capatina 1, Isaac Watson2,3, Oliver J Mundell4,5,6,7, Aneurin J Kennerley1,4,5,6,7,8, William Brackenbury1,9
1Department of Biology, University of York, York, United Kingdom
2Biomedical Imaging Science Department, Leeds Institute of Cardiovascular and Metabolic Medicine, Leeds, United Kingdom
3Department of Chemistry, University of York, York, United Kingdom
4Department of Sport and Exercise Sciences, Manchester Metropolitan University, Manchester, United Kingdom
5Manchester Metropolitan University, Manchester, United Kingdom
6Manchester Metropolitan Institute of Sport, Manchester Metropolitan University, Manchester, United Kingdom
7Wolfson ACTIVE Imaging Laboratory, Manchester Metropolitan University, Manchester, United Kingdom
8Manchester United Football Club, Manchester, United Kingdom
9York Biomedical Research Institute, University of York, York, United Kingdom
Presenting Author: Alina Lavinia Capatina

Synopsis

Motivation:
Goals:
Approach:
Results:
Full abstract & presentation

The full text, figures, and any recorded presentation for this abstract are not shown here. Log in if you are a member or registered attendee with access.

Full abstracts, figures, and presentations for Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition are available to registered attendees. This content becomes freely available to the public roughly two years after the meeting.

To request or purchase access, contact the ISMRM Central Office at info@ismrm.org.

Log in

References

1. James AD, Leslie TK, Kaggie JD, Wiggins L, Patten L, Murphy O'Duinn J, Langer S, Labarthe MC, Riemer F, Baxter G, McLean MA, Gilbert FJ, Kennerley AJ, Brackenbury WJ. Sodium accumulation in breast cancer predicts malignancy and treatment response. Br J Cancer. 2022 Jul;127(2):337-349. doi: 10.1038/s41416-022-01802-w. Epub 2022 Apr 25. PMID: 35462561; PMCID: PMC9296657. [doi] [pmid]
2. Poku LO, Phil M, Cheng Y, Wang K, Sun X. 23 Na-MRI as a Noninvasive Biomarker for Cancer Diagnosis and Prognosis. J Magn Reson Imaging. 2021 Apr;53(4):995-1014. doi: 10.1002/jmri.27147. Epub 2020 Mar 26. PMID: 32219933; PMCID: PMC7984266. [doi] [pmid]
3. Wu B, Warnock G, Zaiss M, Lin C, Chen M, Zhou Z, Mu L, Nanz D, Tuura R, Delso G. An overview of CEST MRI for non-MR physicists. EJNMMI Phys. 2016 Dec;3(1):19. doi: 10.1186/s40658-016-0155-2. Epub 2016 Aug 26. PMID: 27562024; PMCID: PMC4999387. [doi] [pmid]
4. Chan KW, Jiang L, Cheng M, Wijnen JP, Liu G, Huang P, van Zijl PC, McMahon MT, Glunde K. CEST-MRI detects metabolite levels altered by breast cancer cell aggressiveness and chemotherapy response. NMR Biomed. 2016 Jun;29(6):806-16. doi: 10.1002/nbm.3526. Epub 2016 Apr 21. PMID: 27100284; PMCID: PMC4873340. [doi] [pmid]
5. Zhang S, Seiler S, Wang X, Madhuranthakam AJ, Keupp J, Knippa EE, Lenkinski RE, Vinogradov E. CEST-Dixon for human breast lesion characterization at 3 T: A preliminary study. Magn Reson Med. 2018 Sep;80(3):895-903. doi: 10.1002/mrm.27079. Epub 2018 Jan 10. PMID: 29322559; PMCID: PMC5980671. [doi] [pmid]
6. Leslie TK, James AD, Zaccagna F, Grist JT, Deen S, Kennerley A, Riemer F, Kaggie JD, Gallagher FA, Gilbert FJ, Brackenbury WJ. Sodium homeostasis in the tumour microenvironment. Biochim Biophys Acta Rev Cancer. 2019 Dec;1872(2):188304. doi: 10.1016/j.bbcan.2019.07.001. Epub 2019 Jul 23. PMID: 31348974; PMCID: PMC7115894. [doi] [pmid]
7. Miran T, Vogg ATJ, Drude N, Mottaghy FM, Morgenroth A. Modulation of glutathione promotes apoptosis in triple-negative breast cancer cells. FASEB J. 2018 May;32(5):2803-2813. doi: 10.1096/fj.201701157R. Epub 2018 Jan 8. PMID: 29301945. [doi] [pmid]
8. Beatty A, Fink LS, Singh T, Strigun A, Peter E, Ferrer CM, Nicolas E, Cai KQ, Moran TP, Reginato MJ, Rennefahrt U, Peterson JR. Metabolite Profiling Reveals the Glutathione Biosynthetic Pathway as a Therapeutic Target in Triple-Negative Breast Cancer. Mol Cancer Ther. 2018 Jan;17(1):264-275. doi: 10.1158/1535-7163.MCT-17-0407. Epub 2017 Oct 11. PMID: 29021292; PMCID: PMC5892195. [doi] [pmid]
9. Lu H, Samanta D, Xiang L, Zhang H, Hu H, Chen I, Bullen JW, Semenza GL. Chemotherapy triggers HIF-1-dependent glutathione synthesis and copper chelation that induces the breast cancer stem cell phenotype. Proc Natl Acad Sci U S A. 2015 Aug 18;112(33):E4600-9. doi: 10.1073/pnas.1513433112. Epub 2015 Jul 30. PMID: 26229077; PMCID: PMC4547233. [doi] [pmid]

Cite this abstract

http://echo.ismrm.org/p/ISMRM2026/367-02-006